133 related articles for article (PubMed ID: 29572500)
1. Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
Matarraz S; Leoz P; Fernández C; Colado E; Chillón MC; Vidriales MB; González M; Rivera D; Osuna CS; Caballero-Velázquez T; Van Der Velden V; Jongen-Lavrencic M; Gutiérrez O; Bermejo AY; Alonso LG; García MB; De Ramón Sánchez C; García-Donas G; Mateo AG; Recio I; Sánchez-Real J; Mayado A; Gutiérrez ML; Bárcena P; Barrena S; López A; Van Dongen J; Orfao A
Mod Pathol; 2018 Aug; 31(8):1318-1331. PubMed ID: 29572500
[TBL] [Abstract][Full Text] [Related]
2. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Li SS; Yang XW; Zheng Y; Gao YJ; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
[TBL] [Abstract][Full Text] [Related]
4. B & B: basophils and bleeding, an atypical case of acute promyelocytic leukemia.
Lebecque B; Lechevalier N
Blood; 2018 Nov; 132(19):2107. PubMed ID: 30409896
[No Abstract] [Full Text] [Related]
5. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia.
Chu T; Wang H; Lv X; Qi J; Tang Y; Fan Y; Qiu H; Tang X; Fu C; Ruan C; Han Y; Wu DP
Platelets; 2021 Jul; 32(5):677-683. PubMed ID: 32799612
[TBL] [Abstract][Full Text] [Related]
6. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
[TBL] [Abstract][Full Text] [Related]
7. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
[TBL] [Abstract][Full Text] [Related]
8. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
10. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
Altman JK; Rademaker A; Cull E; Weitner BB; Ofran Y; Rosenblat TL; Haidau A; Park JH; Ram SL; Orsini JM; Sandhu S; Catchatourian R; Trifilio SM; Adel NG; Frankfurt O; Stein EM; Mallios G; Deblasio T; Jurcic JG; Nimer S; Peterson LC; Kwaan HC; Rowe JM; Douer D; Tallman MS
Leuk Res; 2013 Sep; 37(9):1004-9. PubMed ID: 23768930
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
[TBL] [Abstract][Full Text] [Related]
12. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
13. Basophilic differentiation in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Snower D; Rubin CM; Reisel H; Variakojis D
Leukemia; 1993 Apr; 7(4):521-6. PubMed ID: 7710454
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.
Hou W; Zhang Y; Jin B; Cao W; Lu M; Yan L; Yang H; Tian X; Hou J; Fu J; Zhao H; Li H; Zhou J
Blood Cells Mol Dis; 2019 Nov; 79():102351. PubMed ID: 31400712
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of fatal bleeding in acute promyelocytic leukemia.
Mantha S; Tallman MS; Devlin SM; Soff GA
Thromb Res; 2018 Apr; 164 Suppl 1():S98-S102. PubMed ID: 29703492
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?
Naymagon L; Mascarenhas J
Leuk Res; 2020 Jul; 94():106356. PubMed ID: 32445941
[TBL] [Abstract][Full Text] [Related]
17. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
[TBL] [Abstract][Full Text] [Related]
19. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
[TBL] [Abstract][Full Text] [Related]
20. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia.
Liu Q; Wang M; Hu Y; Xing H; Chen X; Zhang Y; Zhu P
Leuk Lymphoma; 2014 Apr; 55(4):892-8. PubMed ID: 23962073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]